Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Wang, Haibo ^a   Zhao, Gang ^a   Liu, Xiangping ^a   Sui, Aihua ^a   Yang, Kun ^a   Yao, Ruyong ^a   Wang, Zongbao ^a   Shi, Qiang ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHATE BUFFERED SALINE; RNA; SHORT HAIRPIN RNA; SODIUM CHLORIDE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN; RHOC PROTEIN, HUMAN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA TRANSCRIPTION; TANDEM REPEAT; TUMOR XENOGRAFT; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; CELL STRAIN HCT116; COLORECTAL TUMOR; DRUG SCREENING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY; NUDE MOUSE; PATHOLOGY; TIME; TUMOR VOLUME;

ANIMALS; CELL DEATH; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956454013     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-123     Document Type: Article

References (31)

1. Cancer statistics, 2007. A Jemal R Siegel E Ward T Murray J Xu MJ Thun, CA Cancer J Clin 2007 57 43 66 10.3322/canjclin.57.1.43 17237035
2. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA Cancer J Clin 2007 58 71 96 10.3322/CA.2007.0010
3. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
4. Current treatments and future perspectives in colorectal and gastric cancer. HJ Wilke E Van Cutsem, Ann Oncol 2003 14 i49 55 10.1093/annonc/mdg730 12810459
5. Rho GTPases are over-expressed in human tumors. G Fritz I Just B Kaina, Int J Cancer 1999 81 682 787 10.1002/(SICI)1097-0215(19990531)81:5<682::AID- IJC2>3.0.CO;2-B 10328216
6. Rho GTPases and cell migration. AJ Ridley, J Cell Sci 2001 114 2713 2722 11683406
7. Rho GTPase-dependent transformation by G protein-coupled receptors. IP Whitehead IE Zohn CJ Der, Oncogene 2001 20 1547 1555 10.1038/sj.onc.1204188 11313901
8. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. CG Kleer KL van Golen Y Zhang ZF Wu MA Rubin SD Merajver, Am J Pathol 2002 160 579 584 11839578
9. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. A Horiuchi T Imai C Wang S Ohira Y Feng T Nikaido I Konishi, Lab Invest 2003 83 861 870 12808121
10. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. XR Li F Ji J Ouyang W Wu LY Qian KY Yang, Eur J Surg Oncol 2006 32 1130 1134 10.1016/j.ejso.2006.05.012 16806792
11. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. DI Bellovin KJ Simpson T Danilov E Maynard DL Rimm P Oettgen AM Mercurio, Oncogene 2006 25 6959 6967 10.1038/sj.onc.1209682 16715134
12. The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer. Y Takami M Higashi S Kumagai PC Kuo H Kawana K Koda M Miyazaki K Harigaya, Dig Dis Sci 2008 53 467 473 10.1007/s10620-007-9887-0 17597401
13. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. A Faried LS Faried N Usman H Kato H Kuwano, Ann Surg Oncol 2007 14 3593 3601 10.1245/s10434-007-9562-x 17896152
14. Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity. N Liu F Bi Y Pan L Sun Y Xue Y Shi X Yao Y Zheng D Fan, Clin Cancer Res 2004 10 6239 6247 10.1158/1078-0432.CCR-04-0242 15448013
15. Adenoviral Transfer of Rho Family Proteins to Lung Cancer Cells Ameliorates Cell Proliferation and Motility and Increases Apoptotic Change. T Shimada Y Nishimura T Nishiuma Y Rikitake T Hirase M Yokoyama, Kobe J Med Sci 2007 53 125 134 17684444
16. RhoA and RhoC-siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. HW Sun SL Tong J He Q Wang L Zou SJ Ma HY Tan JF Luo HX Wu, World J Gastroenterol 2007 13 3517 3522 17659701
17. Marked effect of RhoA-specific shRNA-producing plasmids on neurite growth in PC12 cells. YM Fan CP Pang AR Harvey Q Cui, Neurosci Lett 2008 440 170 175 10.1016/j.neulet.2008.05.045 18556119
18. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters. HB Wang XP Liu J Liang K Yang AH Sui YJ Liu, Clin Chem Lab Med 2009 47 811 817 10.1515/CCLM.2009.186 19499974
19. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells. XP Liu HB Wang K Yang AH Sui Q Shi S Qu, J Exp Clin Cancer Res 2009 28 52 10.1186/1756-9966-28-52 19374769
20. The cellular functions of small GTP-binding proteins. A Hall, Science (Wash DC) 1990 249 635 640 10.1126/science.2116664
21. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. SA Benitah PF Valeron L van Aelst CJ Marshall JC Lacal, Biochim Biophys Acta 2004 1705 121 132 15588766
22. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. JJ Fiordalisi PJ Keller AD Cox, Cancer Res 2006 66 3153 3161 10.1158/0008-5472.CAN-05-3116 16540666
23. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. T Kusama M Mukai T Iwasaki M Tatsuta Y Matsumoto H Akedo M Inoue H Nakamura, Gastroenterology 2002 122 308 317 10.1053/gast.2002.31093 11832446
24. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. T Ikoma T Takahashi S Nagano YM Li Y Ohon K Ando T Fujiwara H Fujiwara K Kosai, Clin Cancer Res 2004 10 1192 1200 10.1158/1078-0432.CCR-03-0275 14871999
25. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. W Wang LY Yang GW Huang WQ Lu ZL Yang JQ Yang HL Liu, Br J Cancer 2004 90 2349 2355 15150600
26. RhoA gene expression in colorectal carcinoma. H Wang Y Chen D Cao Y Zhang R Meng J Lu, Zhonghua Yi Xue Za Zhi 2002 82 348 351 11953197
27. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. JY Pille C Denoyelle J Varet JR Bertrand J Soria P Opolon H Lu LL Pritchard JP Vannier C Malvy C Soria H Li, Mol Ther 2005 11 267 274 10.1016/j.ymthe.2004.08.029 15668138
28. RNA interference: a practical approach. MS Duxbury EE Whang, J Surg Res 2004 117 339 344 10.1016/j.jss.2003.09.010 15047140
29. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. I Ganly D Kirn G Eckhardt GI Rodriguez DS Soutar R Otto AG Robertson O Park ML Gulley C Heise DD Von Hoff SB Kaye, Clin Cancer Res 2000 6 798 806 10741699
30. Cancer therapy utilizing an adenoviral vector expressing only E1A. AV Hubberstey M Pavliv RJ Parks, Cancer Gene Ther 2002 9 321 329 10.1038/sj.cgt.7700436 11960282
31. Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model. G Palacios HC Crawford A Vaseva UM Moll, Cell Cycle 2008 7 2584 2590 18719383